258 filings
Page 3 of 13
8-K
a6d hbifq5a
7 Dec 21
Regulation FD Disclosure
12:45pm
8-K
o23rlk zi78rf0e21k
22 Nov 21
Regulation FD Disclosure
8:01am
8-K
wg7aodh kz
2 Nov 21
MIMEDX Announces Third Quarter 2021
4:53pm
8-K
jdt81japw16jm0s9 h0p
13 Sep 21
MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology
6:33am
8-K
e6k khdwg9
3 Aug 21
MIMEDX Announces Second Quarter 2021
5:26pm
8-K
yxr1nj
7 Jul 21
Departure of Directors or Certain Officers
4:05pm
8-K
9cnml 7np
23 Jun 21
Results of Operations and Financial Condition
8:33am
8-K
ojkdb syigv
10 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:19pm
8-K
47d0lam86d1e5sai wwu
3 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:56pm
8-K
jdgdb8
25 May 21
MIMEDX Reminds Shareholders to Pre-Register for the Upcoming
8:31am
8-K
swadzt
12 May 21
Regulation FD Disclosure
8:20am
8-K
vhkh5 v108n
3 May 21
Regulation FD Disclosure
8:00am
8-K
9z2g0z2 cgv6
28 Apr 21
MiMedx Announces First Quarter 2021 Financial and Operating Results
5:09pm
8-K
vbsbos1 m4
21 Apr 21
Amendments to Articles of Incorporation or Bylaws
8:30am
8-K
f4e z94j4bvpij
19 Apr 21
MiMedx Announces Last Patients Last Visits in Three Late-Stage Musculoskeletal Trials with Proprietary Tissue Technology
9:00am
8-K
uqj3ti8o nm
5 Apr 21
Other Events
4:18pm
8-K
qt0esv6sz
30 Mar 21
Changes in Registrant's Certifying Accountant
5:22pm
8-K
4gjgkofsq
10 Mar 21
Regulation FD Disclosure
9:26am
8-K
559xc
9 Mar 21
MiMedx Announces Fourth Quarter and Full Year 2020 Financial and Operating Results
12:00am
8-K
13zh59c9aqq3lubmh
8 Jan 21
Regulation FD Disclosure
9:21pm